Pesticide exposure and its effects on intrauterine and postnatal development / Exposición a plaguicidas y sus efectos en el desarrollo intrauterino y posnatal

Abstract Background: The period between conception and the first two postnatal years is critical and marks the individual, largely determining their health and disease patterns. Objective: To review the effect of pesticide exposure in utero and in the 1st years of life. Materials and methods: The scientific literature in relation to the subject was reviewed, both in animal models and in humans. Results: The presence of various types of pesticides in umbilical cord blood and in meconium is well documented in newborns worldwide, including Mexico. Pesticides have been associated with low birth weight, and various birth defects at the heart, gastrointestinal tract, genitourinary system, musculoskeletal system, and neurodevelopmental disorders. These substances may play a role in the increase in cases of autistic disorder. Conclusions: Despite the evidence, there are no public policies in many countries, including Mexico, to control the sale and use of pesticides. It is required to prevent exposure to these substances in the population and to do follow-up studies in mother-child pairs where exposure is suspected.

Resumen Introducción: El periodo comprendido entre la concepción y los primeros dos años posnatales es crítico y marca al individuo, determinando en buena parte sus patrones de salud y enfermedad. Objetivo: Hacer una revisión sobre el efecto de la exposición a plaguicidas en útero y en los primeros años de vida. Material y métodos: Se revisó la literatura científica en relación con el tema, tanto en modelos animales como en humanos. Resultados: La presencia de diversos tipos de plaguicidas en la sangre de cordón umbilical y en meconio está bien documentada en recién nacidos en todo el mundo, incluyendo México. Los plaguicidas se han asociado con bajo peso al nacer y diversos defectos congénitos a nivel cardiaco, del tracto gastrointestinal, sistema genitourinario y sistema musculoesquelético, así como a trastornos en el desarrollo neurológico. Estas sustancias pueden tener participación en el incremento de casos de trastorno autista. Conclusiones: A pesar de las evidencias, no existen en muchos países, incluyendo México, políticas públicas para controlar la venta y uso de plaguicidas. Se requiere prevenir la exposición a estas substancias en la población y hacer estudios de seguimiento en binomios madre-hijo donde se sospeche exposición.

Sudden Death Report in Mexico (1998-2014).

Introduction: Sudden death (SD) is a health problem worldwide affecting all strata of the population. The main cause of SD is ischemic heart disease (IHD). The aims of the study were as follows: (i) to analyze the incidence of deaths from IHD in two successive periods (1998-2006 and 2007-2015) to visualize the magnitude of the problem and (ii) to review the official reports of SD in the same lapse of time. Materials and Methods: During that period, instantaneous death (ISD) and death that occurred in the first 24 h after the onset of symptoms were analyzed according to the official databases of National Institute of Statistics and Geography (INEGI) and National Health Information System (SINAIS). Results: There was an under-registration of SD cases in Mexico. Only 1394 cases of ISD were recorded officially in 17 years period of study, whereas it is estimated that 33,000 cases occur annually, exclusively due to sudden cardiac death. Conclusion: There is a serious gap in the official epidemiological information; placing the real problem in perspective would help to establish the adequate public policies for both, prevention and investigation of the causes of SD in Mexico.

Introducción: La muerte súbita (MS) es un problema mundial de salud que afecta a todos los estratos de la población. La principal causa de MS es la cardiopatía isquémica. Los objetivos del estudio fueron: i) Analizar la incidencia de muertes por cardiopatía isquémica en dos períodos sucesivos (1998-2006 y 2007-2015) para visualizar la magnitud del problema, y ii) revisar los informes oficiales de MS en los mismos lapsos. Metodología: Durante ese período, se analizaron la muerte instantánea (MSI) y la muerte ocurrida en las primeras 24 h después del inicio de los síntomas (MS24h) de acuerdo con las bases de datos oficiales del Instituto Nacional de Estadística y Geografía (INEGI) y el Sistema Nacional de Información de Salud (SINAIS). Resultados: Existe un subregistro de casos de MS en México. Solo 1,394 casos de MSI se registraron oficialmente en el período de estudio de 17 años, mientras que se estima que ocurren 33,000 casos al año, solo por muerte súbita cardíaca. Conclusión: Existe una subregistro de información epidemiológica oficial; poner el problema real en perspectiva ayudaría a establecer políticas públicas adecuadas tanto para la prevención como para la investigación de las causas de la MS en México.

Sudden Death Report in Mexico (1998-2014).

Introduction: Sudden death (SD) is a health problem worldwide affecting all strata of the population. The main cause of SD is ischemic heart disease (IHD). The aims of the study were as follows: (i) to analyze the incidence of deaths from IHD in two successive periods (1998-2006 and 2007-2015) to visualize the magnitude of the problem and (ii) to review the official reports of SD in the same lapse of time. Materials and Methods: During that period, instantaneous death (ISD) and death that occurred in the first 24 h after the onset of symptoms were analyzed according to the official databases of National Institute of Statistics and Geography (INEGI) and National Health Information System (SINAIS). Results: There was an under-registration of SD cases in Mexico. Only 1394 cases of ISD were recorded officially in 17 years period of study, whereas it is estimated that 33,000 cases occur annually, exclusively due to sudden cardiac death. Conclusion: There is a serious gap in the official epidemiological information; placing the real problem in perspective would help to establish the adequate public policies for both, prevention and investigation of the causes of SD in Mexico.

Introducción: La muerte súbita (MS) es un problema mundial de salud que afecta a todos los estratos de la población. La principal causa de MS es la cardiopatía isquémica. Los objetivos del estudio fueron: i) Analizar la incidencia de muertes por cardiopatía isquémica en dos períodos sucesivos (1998-2006 y 2007-2015) para visualizar la magnitud del problema, y ii) revisar los informes oficiales de MS en los mismos lapsos. Metodología: Durante ese período, se analizaron la muerte instantánea (MSI) y la muerte ocurrida en las primeras 24 h después del inicio de los síntomas (MS24h) de acuerdo con las bases de datos oficiales del Instituto Nacional de Estadística y Geografía (INEGI) y el Sistema Nacional de Información de Salud (SINAIS). Resultados: Existe un subregistro de casos de MS en México. Solo 1,394 casos de MSI se registraron oficialmente en el período de estudio de 17 años, mientras que se estima que ocurren 33,000 casos al año, solo por muerte súbita cardíaca. ­. Conclusión: Existe una subregistro de información epidemiológica oficial; poner el problema real en perspectiva ayudaría a establecer políticas públicas adecuadas tanto para la prevención como para la investigación de las causas de la MS en México.

Sudden Death Report in Mexico (1998-2014) / Reporte de muerte súbita en Mexico (1998-2014)

Abstract Introduction: Sudden death (SD) is a health problem worldwide affecting all strata of the population. The main cause of SD is ischemic heart disease (IHD). The aims of the study were as follows: (i) to analyze the incidence of deaths from IHD in two successive periods (1998-2006 and 2007-2015) to visualize the magnitude of the problem and (ii) to review the official reports of SD in the same lapse of time. Materials and Methods: During that period, instantaneous death (ISD) and death that occurred in the first 24 h after the onset of symptoms were analyzed according to the official databases of National Institute of Statistics and Geography (INEGI) and National Health Information System (SINAIS). Results: There was an under-registration of SD cases in Mexico. Only 1394 cases of ISD were recorded officially in 17 years period of study, whereas it is estimated that 33,000 cases occur annually, exclusively due to sudden cardiac death. Conclusion: There is a serious gap in the official epidemiological information; placing the real problem in perspective would help to establish the adequate public policies for both, prevention and investigation of the causes of SD in Mexico.

Resumen Introducción: La muerte súbita (MS) es un problema mundial de salud que afecta a todos los estratos de la población. La principal causa de MS es la cardiopatía isquémica. Los objetivos del estudio fueron: i) Analizar la incidencia de muertes por cardiopatía isquémica en dos períodos sucesivos (1998-2006 y 2007-2015) para visualizar la magnitud del problema, y ii) revisar los informes oficiales de MS en los mismos lapsos. Metodología: Durante ese período, se analizaron la muerte instantánea (MSI) y la muerte ocurrida en las primeras 24 h después del inicio de los síntomas (MS24h) de acuerdo con las bases de datos oficiales del Instituto Nacional de Estadística y Geografía (INEGI) y el Sistema Nacional de Información de Salud (SINAIS). Resultados: Existe un subregistro de casos de MS en México. Solo 1,394 casos de MSI se registraron oficialmente en el período de estudio de 17 años, mientras que se estima que ocurren 33,000 casos al año, solo por muerte súbita cardíaca. Conclusión: Existe una subregistro de información epidemiológica oficial; poner el problema real en perspectiva ayudaría a establecer políticas públicas adecuadas tanto para la prevención como para la investigación de las causas de la MS en México.

The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National Study.

BACKGROUND: Current metastatic colorectal cancer (mCRC) therapy uses monoclonal antibodies against the epidermal growth factor receptor. This treatment is only useful in the absence of K-RAS gene mutations; therefore the study of such mutations is part of a personalized treatment. The aim of this work is to determine the frequency and type of the most common K-RAS mutations in Mexican patients with metastatic disease by nucleotide sequencing. PATIENTS AND METHODS: We studied 888 patients with mCRC from different regions of Mexico. The presence of mutations in exon 2, codons 12 and 13, of the K-RAS gene was determined by nucleotide sequencing. RESULTS: Patients exhibited K-RAS gene mutations in 35% (310/888) of cases. Mutation frequency of codons 12 and 13 was 71% (221/310) and 29% (89/310), respectively. The most common mutation (45.7%) in codon 12 was c.35G>A (p.G12D), whereas the one in codon 13 was c.38G>A (p.G13D) (78.7%). DISCUSSION: Given the frequency of K-RAS mutations in Mexicans, making a genetic study before deciding to treat mCRC patients with monoclonal antibodies is indispensable.

Genetic structure of Mexican Mestizos with type 2 diabetes mellitus based on three STR loci.

BACKGROUND: The aims of this population genetics study were: 1) to ascertain whether Mexicans with type 2 diabetes mellitus (DM) were genetically homogeneous and 2) to compare the genetic structure of this selected population with the previously reported data of four random populations (Nuevo León, Hispanics, Chihuahua, and Central Region of Mexico). METHODS: A sample of 103 unrelated individuals with DM and whose 4 grandparents were born in five zones of Mexico was interviewed in 32 Medical Units in the Mexican Institute of Social Security (IMSS). The non-coding STRs D16S539, D7S820, and D13S317 were analyzed. RESULTS: Genotype distribution was in agreement with Hardy-Weinberg expectations for all three markers. Allele frequencies were found to be similar between the selected population and the four random populations. Gene diversity analysis suggested that more than 99.57% of the total gene diversity could be attributed to variation between individuals within the population and 0.43% between the populations. CONCLUSIONS: According to the present and previous studies using molecular and non-molecular nuclear DNA markers not associated with any disease, the Mexican Mestizo population is found to be genetically homogeneous and therefore the genetic causes of DM are less heterogeneous, thereby simplifying genetic epidemiological studies as has been found in a previous study with the same design in Mexican women with breast cancer.

Genetic structure of Mexican Mestizo women with breast cancer based on three STR loci.

The aim of this population genetics study was to compare the genetic structure of Mexican women with breast cancer (BrCa) with previously reported data of four random populations (Nuevo León, Hispanics, Chihuahua, and Central Region of Mexico). A sample of 115 unrelated women with BrCa and whose four grandparents were born in five zones of Mexico were interviewed at a reference hospital in Northeastern Mexico. Noncodifying STRs D7S820, D13S317, and D16S39 were analyzed; genotype distribution was in agreement with Hardy-Weinberg expectations for all three markers. Similar allele frequencies among four random populations and this selected population were found. According with this and previous studies using molecular and nonmolecular nuclear DNA markers not associated with any disease, Mexican Mestizo population is genetically homogeneous and therefore, genetic causes of BrCa are less heterogeneous, simplifying genetic epidemiologic studies.